RCT of Meditation and Health Education on CIMT and MACE in Black Women and Men
Launched by MAHARISHI INTERNATIONAL UNIVERSITY · Nov 30, 2022
Trial Information
Current as of January 13, 2025
Completed
Keywords
ClinConnect Summary
This was a randomized, single-blind, controlled, community-based trial comparing the clinical efficacy of the Transcendental Meditation (TM) program carotid intima-media thickness and major adverse cardiovascular events (MACE) in 197 African American men and women at high risk for ASCVD. This trial compared the efficacy of the TM program to health education over one year on cIMT. Eligible participants were randomly allocated to either the TM program or health education (HE). The primary outcome was carotid intima-media thickness (IMT) assessed by B-mode ultrasonography at baseline and 12 mo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • race/ethnicity: African American, self-identified, age: no upper limit, gender: male or female, minimum carotid artery intima medial thickness (IMT) of at least .72 mm for men and .65 mm for women or long-term history of diabetes, myocardial infarction, coronary artery revascularization or coronary angiography indicating at least one vessel with 50% stenosis.
- Exclusion Criteria:
- • myocardial infarction, unstable angina, CABG, percutaneous transluminal coronary angioplasty (PTCA), or stroke within the previous three months, carotid artery endarterectomy, arrhythmia - atrial fibrillation, second or third degree AV block, congestive heart failure - class III or IV or ejection fraction less than 30 %, clinically significant valvular heart disease, clinically significant hepatic or renal failure, major psychiatric disorders, current alcohol or other drug abuse dependency disorder, non-cardiac life-threatening illness, and participating in a formal stress management program
- • -
Trial Officials
Robert H Schneider, M.D.
Principal Investigator
Maharishi International University
About Maharishi International University
Maharishi International University (MIU) is a pioneering institution dedicated to advancing research and education in the fields of consciousness, health, and wellness. With a commitment to integrating ancient wisdom and modern science, MIU fosters innovative clinical trials that explore the effects of mind-body practices on health outcomes. The university’s multidisciplinary approach combines expertise in psychology, medicine, and holistic health, making it a leader in the investigation of alternative and complementary therapies. MIU's research initiatives aim to contribute to evidence-based practices that enhance well-being and promote sustainable health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials